Latest commercialization of proprietary NanoMetalene surface technology.
The Shoreline ACS System from SeaSpine Holdings Corporation is designed to deliver maximum flexibility and modularity, offering zero- and low-profile plating options. Image courtesy of SeaSpine.
SeaSpine Holdings Corporation, a global developer of surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the Shoreline Anterior Cervical Standalone (ACS) System, featuring TruProfile technology.
“Shoreline with TruProfile has met the challenge of combining ease of implant placement and plate fixation to allow for a more responsive approach to specific patient requirements,” stated Dr. James Bruffey, an orthopedic surgeon in San Diego, Calif.
Carlsbad, Calif.-based SeaSpine designs, develops, and commercializes surgical solutions for treating spinal disorders. SeaSpine has a portfolio of orthobiologics and spinal implant solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. SeaSpine’s orthobiologics products consist of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures. SeaSpine’s spinal implant portfolio consists of products to facilitate spinal fusion in minimally invasive surgery (MIS), complex spine, deformity and degenerative procedures. SeaSpine currently markets its products in the United States and in over 30 countries worldwide.